Nyxoah Details Early U.S. Genio Launch, Reimbursement Update at Oppenheimer MedTech Conference 2026 [Yahoo! Finance]
Nyxoah SA - Ordinary Shares (NYXH)
Company Research
Source: Yahoo! Finance
70 VAC approvals with active implants at 50+ accounts, and reported $4.5 million of U.S. revenue in Q4 with management forecasting strong double-digit growth. The Genio system differentiates via minimally invasive, single-incision, battery-free bilateral stimulation and an “implant for life” label (12-year longevity); pivotal DREAM data showed a AHI responder rate and strong supine performance with 82% of implanted patients achieving AHI Reimbursement is largely intact—commercial payers account for 90% of current business—and CMS mapped both technologies to APC level 5 with a facility fee of ; Nyxoah targets profitability at about EUR 150 million revenue assuming 80% gross margins, aided by cost reductions like a new activation chip. Interested in Nyxoah SA? Here are five stocks we like better. Nyxoah (NASDAQ:NYXH) used its presentation at Oppenheimer's MedTech and Services Conference 2026 to outline the company's early U.S. launch progress for its Genio system, a neuromodula
Show less
Read more
Impact Snapshot
Event Time:
NYXH
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NYXH alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NYXH alerts
High impacting Nyxoah SA - Ordinary Shares news events
Weekly update
A roundup of the hottest topics
NYXH
News
- Nyxoah (NYXH) had its "overweight" rating reaffirmed by Cantor Fitzgerald. They now have a $11.00 price target on the stock.MarketBeat
- Publication relating to transparency notificationsGlobeNewswire
- Nyxoah (NYXH) had its price target lowered by Stifel Nicolaus from $11.00 to $10.00. They now have a "buy" rating on the stock.MarketBeat
- Nyxoah SA (NYXH) Q4 2025 Earnings Call Highlights: U.S. Launch Success and Financial Challenges [Yahoo! Finance]Yahoo! Finance
- Nyxoah Q4 Earnings Call Highlights [Yahoo! Finance]Yahoo! Finance
NYXH
Earnings
- 3/19/26 - Beat
NYXH
Sec Filings
- 3/26/26 - Form S-8
- 3/26/26 - Form 20-F
- 3/19/26 - Form 6-K
- NYXH's page on the SEC website